Freshfields is advising Merck on its $10bn acquisition of respiratory-focused pharmaceutical company Verona Pharma, in a major US mandate for the UK-headquartered firm, with Latham & Watkins advising Verona.
The Freshfields team is led by US corporate and M&A co-head Damien Zoubek and M&A partner Jenny Hochenberg in New York, while key lawyers in London assisting on the deal include corporate partners Rhys Evans and Kate Cooper.
Your limit of 1 article in 30 days is up. Please login for full access or subscribe.
Corporate users - click here for simple access (no password needed).
For more information, please contact [email protected]
